Track the Mentice AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Mentice AB has logged 5 insider filings. Market capitalisation: €417.7m. The latest transaction was reported on 18 June 2026 (Purchase). Among the most active insiders: Lawrence Howell. Every trade is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€6m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Mentice AB Hold (neutral), based on 2 analysts. Average price target: SEK 22.00.
33Σ signal
Buys €6mn/a Sells
Fundamental score
Ranked 24,162 of 29,024 companies
28.2
score / 100
Value
17
Quality
40
FCF yld-9.3%
Earn yld-8.5%
EV/EBITDA·
ROE-4.2%
Gross mgn90%
Net mgn-12%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,850 shares@ €1.65640.0011% mcap100.0% of flowAktieISINISIN SE0012673291FI:A003P260-1
5 of 5 declarations
About Mentice AB
Mentice AB is a company focused on developing simulation solutions for training in interventional medicine. It is listed on the Stockholm Stock Exchange (XSTO).